Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis

被引：0

作者：

Bumma, Naresh ^{[1
]}

Reu, Frederic J. ^{[1
]}

Samaras, Christy ^{[1
]}

Duong, Hien K. ^{[1
]}

Smith, Mitchell R. ^{[1
]}

Valent, Jason ^{[1
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
Sidana, Surbhi
Narkhede, Mayur
Elson, Paul
Hastings, Debbie
Faiman, Beth
Valent, Jason
Samaras, Christy
Hamilton, Kimberly
Liu, Hien K.
Smith, Mitchell R.
Reu, Frederic J.
PLOS ONE, 2017, 12 (03):
[2] Neuropathy and Efficacy Of Weekly Subcutaneous Bortezomib In Myeloma and AL Amyloidosis
Sidana, Surbhi
Faiman, Beth
Elson, Paul
Smith, Mitchell R.
Dean, Robert M.
Valent, Jason
Samaras, Christy
Duong, Hien K.
Hastings, Debbie
Bruening, Kellie
Reu, Frederic J.
BLOOD, 2013, 122 (21)
[3] Once Weekly Subcutaneous Bortezomib, Cyclophosphamide, and Dexamethasone As Induction Therapy for All AL Amyloidosis
Abbas, Hashim
Rybicki, Lisa A.
Reu, Frederic J.
Samaras, Christy
Smith, Mitchell R.
Hastings, Debbie
Valent, Jason
BLOOD, 2016, 128 (22)
[4] Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study
Reece, Donna E.
Hegenbart, Ute
Sanchorawala, Vaishali
Merlini, Giampaolo
Palladini, Giovanni
Blade, Joan
Fermand, Jean-Paul
Hassoun, Hani
Heffner, Leonard
Vescio, Robert A.
Liu, Kevin
Enny, Christopher
Esseltine, Dixie-Lee
van de Velde, Helgi
Cakana, Andrew
Comenzo, Raymond L.
BLOOD, 2011, 118 (04) : 865 - 873
[5] Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Bringhen, Sara
Larocca, Alessandra
Rossi, Davide
Cavalli, Maide
Genuardi, Mariella
Ria, Roberto
Gentili, Silvia
Patriarca, Francesca
Nozzoli, Chiara
Levi, Anna
Guglielmelli, Tommasina
Benevolo, Giulia
Callea, Vincenzo
Rizzo, Vincenzo
Cangialosi, Clotilde
Musto, Pellegrino
De Rosa, Luca
Liberati, Anna Marina
Grasso, Mariella
Falcone, Antonietta P.
Evangelista, Andrea
Cavo, Michele
Gaidano, Gianluca
Boccadoro, Mario
Palumbo, Antonio
BLOOD, 2010, 116 (23) : 4745 - 4753
[6] Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients.
Bringhen, Sara
Larocca, Alessandra
Rossi, Davide
Romano, Alessandra
Genuardi, Mariella
Ria, Roberto
Leoni, Pietro
Patriarca, Francesca
Nozzoli, Chiara
Guglielmelli, Tommasina
Benevolo, Giulia
Callea, Vincenzo
Gentilini, Fabiana
Elice, Francesca
Olivero, Barbara
Grasso, Mariella
Falcone, Antonietta Pia
Gottardi, Daniela
Montefusco, Vittorio
Allegra, Alessandro
Rizzo, Manuela
Leonardi, Giovanna
Oddolo, Daniela
Morabito, Fortunato
Boccadoro, Mario
Palumbo, Antonio
BLOOD, 2010, 116 (21) : 1248 - 1249
[7] Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis
Hughes, Michael Sang
Lentzsch, Suzanne
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 1063 - 1074
[8] Efficacy and safety of bortezomib in once weekly vs. twice weekly dosing in the treatment of multiple myeloma
Ang, Kwan-Keat
Beechinor, Ryan
Quan, Michelle
Tuscano, Joseph
Rosenberg, Aaron
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S152 - S152
[9] Efficacy and safety of bortezomib in systemic AL amyloidosis - A preliminary report.
Wechalekar, Ashutosh
Gillmore, Julian
Lachmann, Helen
Offer, Mark
Hawkins, Philip
BLOOD, 2006, 108 (11) : 42A - 42A
[10] Efficacy and safety of a modified daratumumab/bortezomib/dexamethasone regimen using once weekly bortezomib in relapsed refractory multiple myeloma
Abousaud, Marin
Dressler, Emily
Duda, Jessica
Johnson, Emily
Kennedy, LeAnne
Rodriguez, Cesar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E150 - E151

← 1 2 3 4 5 →